Editorial | Volume: 15, Issue: 10, October, 2025
Editorial | Volume: 15, Issue: 10, October, 2025
No abstract is available.
Chatterjee B. The role of AI and ML in advancing electronically controlled drug delivery systems. J Appl Pharm Sci. 2025;15(10):001-002. https://doi.org/10.7324/JAPS.2025.264701ED
1. Kogai T, Sato J, Yasuda H, Ayame T, Ozaki A, Takagi E, et al. Effects of switching from MiniMedTM 640G to 770G on continuous glucose monitoring metrics and DTR-QOL scores: an observational study of Japanese people with type 1 diabetes mellitus. J Diabetes Investig. 2024;16(2):326–33. doi: https://doi.org/10.1111/JDI.14350
2. Hoffmann SV, O’Shea JP, Galvin P, Jannin V, Griffin BT. State-of-the-art and future perspectives in ingestible remotely controlled smart capsules for drug delivery: a GENEGUT review. Eur J Pharm Sci. 2024;203:106911. doi: https://doi.org/10.1016/J.EJPS.2024.106911
3. Vibrant. Chronic constipation drug-free treatment? Vibrant Gastro®; 2022. Available from: https://www.vibrantgastro.com/
4. Vadlapatla R, Wong EY, Gayakwad SG. Electronic drug delivery systems: an overview. J Drug Deliv Sci Technol. 2017;41:359–66. doi: https://doi.org/10.1016/J.JDDST.2017.08.008
5. DiNuzzo M. How artificial intelligence enables modeling and simulation of biological networks to accelerate drug discovery. Front Drug Discov. 2022;2:1019706. doi: https://doi.org/10.3389/FDDSV.2022.1019706/XML/NLM
6. Andhari SS, Wavhale RD, Dhobale KD, Tawade BV, Chate GP, Patil YN, et al. Self-propelling targeted magneto-nanobots for deep tumor penetration and pH-responsive intracellular drug delivery. Sci Rep. 2020;10(1):1–16. doi: https://doi.org/10.1038/S41598-020-61586-Y
7. Gupta A, Soni S, Chauhan N, Khanuja M, Jain U. Nanobots-based advancement in targeted drug delivery and imaging: an update. J Control Rel. 2022;349:97–108. doi: https://doi.org/10.1016/J.JCONREL.2022.06.020
8. ClinicalTrials.gov. Explore the performance of IntelliCap; 2014. Available from: https://clinicaltrials.gov/study/NCT02025348?rank=1
9. ClinicalTrials.gov. User evaluation of the MiniMed 620G and 640G Insulin Pumps; 2016. Available from: https://clinicaltrials.gov/study/NCT01726621?cond=Diabetes%20Mellitus%20Type%202&term=minimed&rank=2
10. ClinicalTrials.gov. Smartguard use in real life: a longitudinal study in patients with type 1 diabetes; 2018. Available from: https://clinicaltrials.gov/study/NCT03047486?cond=diabetes&term=smartguard&rank=1
Year
Month